Alembic Pharma to raise up to ₹300 cr via NCD

Updated - September 10, 2018 at 08:53 PM.

The board of Alembic Pharmaceuticals has approved a proposal to raise up to ₹300 crore through non-convertible debentures on private placement basis. Shares of Alembic Pharma slipped 1.6 per cent at ₹628.45 on the BSE.

Published on September 10, 2018 15:23